Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV

This study has been completed.
Sponsor:
Information provided by:
Clinical Trial Agency of HIV Study Group
ClinicalTrials.gov Identifier:
NCT00256828
First received: November 21, 2005
Last updated: October 15, 2007
Last verified: November 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: November 2006
  Estimated Primary Completion Date: No date given
No publications provided by Clinical Trial Agency of HIV Study Group

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):